Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
deals
5
×
fda
5
×
life sciences
national blog main
clinical trials
boston blog main
boston top stories
startups
alexion pharmaceuticals
boston
drugs
investing
medical device
national top stories
new york blog main
raleigh-durham blog main
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
4d molecular therapeutics
abbvie
achaogen
acne
adams street partners
agenus
alnylam pharmaceuticals
amyotrophic lateral sclerosis (als)
antibiotics
astrazeneca
auris health
autoimmune disorders
avexis
bayer
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
biomx
bladder cancer
boehringer ingelheim
What
disease
5
×
drug
medicines
deal
pharma
pharmaceuticals
therapeutics
alternative
approved
autoimmune
bacteria
bio
biopharma
building
business
candidate
caught
causing
companies
company
developer
dicerna
digital
epidemic
established
exited
expensive
eye
fatty
fda
fighting
firm
frenzied
gene
growing
hepatitis
infections
infectious
intended
known
Language
unset
Current search:
biotech
×
disease
×
deals
×
fda
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed